Homeostatic MyD88-dependent signals cause lethal inflamMation in the absence of A20
暂无分享,去创建一个
Bettina L. Lee | A. Ma | B. Malynn | Rita M. Tavares | Rommel Advincula | Emre E. Turer | N. Shifrin | Erwan Mortier | O. Hitotsumatsu | Erwan Mortier | Averil Ma | Barbara A. Malynn | Nataliya Shifrin | Osamu Hitotsumatsu | Rommel Advincula | Bettina Lee
[1] H. Shu,et al. Mechanisms of the TRIF-induced Interferon-stimulated Response Element and NF-κB Activation and Apoptosis Pathways* , 2004, Journal of Biological Chemistry.
[2] F. Liew,et al. ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance , 2004, Nature Immunology.
[3] Sakae Tanaka,et al. Severe osteopetrosis, defective interleukin‐1 signalling and lymph node organogenesis in TRAF6‐deficient mice , 1999, Genes to cells : devoted to molecular & cellular mechanisms.
[4] Charles A. Janeway,et al. IRAK-M Is a Negative Regulator of Toll-like Receptor Signaling , 2002, Cell.
[5] F. Martinon,et al. RIP1 is an essential mediator of Toll-like receptor 3–induced NF-κB activation , 2004, Nature Immunology.
[6] D. Goeddel,et al. The tumor necrosis factor-inducible zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-kappaB activation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[7] A. Yoshimura,et al. SOCS1 Deficiency Causes a Lymphocyte-Dependent Perinatal Lethality , 1999, Cell.
[8] A. Ma,et al. Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. , 2000, Science.
[9] Ruslan Medzhitov,et al. Role of toll-like receptors in spontaneous commensal-dependent colitis. , 2006, Immunity.
[10] Jiahuai Han,et al. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling , 2003, Nature.
[11] Shizuo Akira,et al. Toll/IL-1 Receptor Domain-Containing Adaptor Inducing IFN-β (TRIF) Associates with TNF Receptor-Associated Factor 6 and TANK-Binding Kinase 1, and Activates Two Distinct Transcription Factors, NF-κB and IFN-Regulatory Factor-3, in the Toll-Like Receptor Signaling 1 , 2003, The Journal of Immunology.
[12] R. Sartor,et al. Role Of Commensal Enteric Bacteria In The Pathogenesis Of Immune-Mediated Intestinal Inflammation: Lessons From Animal Models And Implications For Translational Research , 2005, Journal of pediatric gastroenterology and nutrition.
[13] Joshua S. Yuan,et al. Real-time PCR Statistics PCR Encyclopedia , 2006 .
[14] S. Akira,et al. Microbial recognition by Toll-like receptors. , 2004, Journal of dermatological science.
[15] D. Wallach. Faculty Opinions recommendation of De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. , 2004 .
[16] R. Medzhitov,et al. Role of the innate immune system and host-commensal mutualism. , 2006, Current topics in microbiology and immunology.
[17] K. Rajewsky,et al. Interleukin-10-deficient mice develop chronic enterocolitis , 1993, Cell.
[18] A. Shahangian,et al. Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response , 2006, Nature.
[19] Ruslan Medzhitov,et al. Toll-Like Receptor Signaling Pathways , 2003, Science.
[20] R. Germain,et al. Dynamic imaging of dendritic cell extension into the small bowel lumen in response to epithelial cell TLR engagement , 2006, The Journal of experimental medicine.
[21] T. Maniatis,et al. IKKε and TBK1 are essential components of the IRF3 signaling pathway , 2003, Nature Immunology.
[22] Hong-Bing Shu,et al. A20 is a potent inhibitor of TLR3‐ and Sendai virus‐induced activation of NF‐κB and ISRE and IFN‐β promoter , 2004 .
[23] M S Boguski,et al. The A20 cDNA induced by tumor necrosis factor alpha encodes a novel type of zinc finger protein. , 1990, The Journal of biological chemistry.
[24] D. Metcalf,et al. The development of fatal myocarditis and polymyositis in mice heterozygous for IFN-gamma and lacking the SOCS-1 gene. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[25] P. Ricciardi-Castagnoli,et al. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria , 2001, Nature Immunology.
[26] Shizuo Akira,et al. TLR signaling pathways. , 2004, Seminars in immunology.
[27] S. Akira,et al. Role of Adaptor TRIF in the MyD88-Independent Toll-Like Receptor Signaling Pathway , 2003, Science.
[28] G. Stark,et al. SIGIRR, a negative regulator of Toll-like receptor–interleukin 1 receptor signaling , 2003, Nature Immunology.
[29] Matthew T Wheeler,et al. The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses , 2004, Nature Immunology.
[30] Katherine A. Fitzgerald,et al. Rip1 Mediates the Trif-dependent Toll-like Receptor 3- and 4-induced NF-κB Activation but Does Not Contribute to Interferon Regulatory Factor 3 Activation* , 2005, Journal of Biological Chemistry.
[31] Joshua S. Yuan,et al. Real-time PCR Statistics , 2006 .
[32] Hidde L Ploegh,et al. CX3CR1-Mediated Dendritic Cell Access to the Intestinal Lumen and Bacterial Clearance , 2005, Science.
[33] Ruslan Medzhitov,et al. Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis , 2004, Cell.
[34] Hong-Bing Shu,et al. A20 is a potent inhibitor of TLR3- and Sendai virus-induced activation of NF-kappaB and ISRE and IFN-beta promoter. , 2004, FEBS letters.
[35] M. Mann,et al. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6 , 2006, Nature.
[36] S. Akira,et al. Unresponsiveness of MyD88-deficient mice to endotoxin. , 1999, Immunity.
[37] F. Liew,et al. Negative regulation of Toll-like receptor-mediated immune responses , 2005, Nature Reviews Immunology.
[38] Makoto Nakanishi,et al. A20 Is a Negative Regulator of IFN Regulatory Factor 3 Signaling1 , 2005, The Journal of Immunology.
[39] D. Kastner,et al. CATERPILLERs, pyrin and hereditary immunological disorders , 2006, Nature Reviews Immunology.
[40] Ruslan Medzhitov,et al. Control of adaptive immune responses by Toll-like receptors. , 2002, Current opinion in immunology.
[41] S. Paul,et al. Functions of interleukin 1 receptor antagonist in gene knockout and overproducing mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[42] S. Akira,et al. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. , 1998, Immunity.
[43] Govinda Rao,et al. IRF3 mediates a TLR3/TLR4-specific antiviral gene program. , 2002, Immunity.
[44] Somasekar Seshagiri,et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling , 2004, Nature.
[45] References , 1971 .
[46] T. Kaisho,et al. Dendritic-cell function in Toll-like receptor- and MyD88-knockout mice. , 2001, Trends in immunology.
[47] Zhijian J. Chen,et al. Activation of the IκB Kinase Complex by TRAF6 Requires a Dimeric Ubiquitin-Conjugating Enzyme Complex and a Unique Polyubiquitin Chain , 2000, Cell.
[48] J. Gordon,et al. Commensal Host-Bacterial Relationships in the Gut , 2001, Science.
[49] Daniel R. Caffrey,et al. LPS-TLR4 Signaling to IRF-3/7 and NF-κB Involves the Toll Adapters TRAM and TRIF , 2003, The Journal of experimental medicine.
[50] Kenji Nakanishi,et al. SOCS-1 participates in negative regulation of LPS responses. , 2002, Immunity.